7/15/2019 2:03:48 AM
AstraZeneca: FDA Issues Complete Response Letter Regarding SNDA For Farxiga
7/12/2019 2:04:40 AM
AstraZeneca Says Imfinzi Granted US Orphan Drug Designation For SCLC
7/1/2019 2:15:20 AM
AstraZeneca: Forxiga Receives Positive EU CHMP Opinion For
DECLARE-TIMI 58 Cardiovascular Outcomes Data
7/1/2019 2:14:23 AM
AstraZeneca Says Fasenra Receives Positive EU CHMP Opinion For Self
6/19/2019 2:05:20 AM
AstraZeneca Says Lynparza Approved In Japan For 1st-line Maintenancetherapy
6/19/2019 2:04:29 AM
AstraZeneca Says Breztri Aerosphere Approved In Japan For Patients With COPD
6/18/2019 2:08:03 AM
AstraZeneca Says EC Approves Lynparza For 1st-line Maintenance
treatment Of BRCA-mutated Advanced Ovarian Cancer
6/17/2019 2:02:17 AM
AstraZeneca Reports Detailed Results From Interim Analysis Of Phase III ASCEND Trial
6/6/2019 2:06:56 AM
AstraZeneca Reports Positive Results From Phase 3 ELEVATE-TN Trial Of Calquence
6/3/2019 9:06:39 AM
Starpharma Signs Development And Option Agreement With AstraZeneca
6/2/2019 9:18:19 AM
AstraZeneca Presents 3-Yr Overall Survival Results From Phase III PACIFIC Trial Of IMFINZI
6/2/2019 9:16:51 AM
AstraZeneca And Merck Announce Detailed Results From Phase 3 POLO Trial Of LYNPARZA Tablets
5/16/2019 8:08:23 AM
AstraZeneca To Present New Research Across Oncology Portfolio At ASCO Meeting